ROY S. PAYNE, Magistrate Judge.
Defendant moves to exclude testimony of Dr. Raymundo Arroyave, one of Plaintiff's technical experts. Def.'s Mot. to Strike [Dkt. # 119]. First, Defendant complains that Arroyave relies on flawed and unreliable testimony of two other witnesses, John Hardesty and Dr. Vallerie DeLeon. Id. at 3-7. Second, Defendant contends Arroyave's opinion contradicts the Court's claim construction rulings. Id. at 7-8. Finally, Defendant moves to strike Arroyave's supplemental report as improper and untimely. Id. at 8-13.
Defendant first complains about Arroyave's reliance on certain testing by two other experts, John Hardesty and Dr. Vallerie DeLeon. Hardesty designed and implemented a test procedure to gather samples for analysis. DeLeon then analyzed those samples using x-ray diffraction (XRD) and x-ray fluorescence (XRF). Defendant separately attacks Hardesty's and DeLeon's methodologies as unreliable, and therefore alleges Arroyave's analysis should also be stricken as based on faulty underlying analysis. Def.'s Mot. [Dkt. # 119] at 3-7. Defendant also criticizes Arroyave's interpretation of XRD spectra as "littered with suspect conclusions" and "overlook[ing] inconsistencies" to arrive at his opinions. Id. at 6-7.
The Court rejects Defendant's challenge for two reasons. First, Arroyave's reliance on Hardesty's and DeLeon's work doesn't put his own methodology in question. As a technical expert on infringement, Arroyave's role in this litigation is to analyze inputs provided to him that relate to whether the claim limitations are met by the accused products. That Arroyave might rely on other experts' analyses as inputs to forming his opinion does not make his own analysis unreliable under Daubert. Regardless, if the Court grants Defendant's motion to exclude testimony of Hardesty or DeLeon, the Court will consider the impact on Arroyave's opinion, if any.
Second, Defendant's claim that Arroyave's actual interpretation of XRD spectra is "littered with suspect conclusions" and "overlooks inconsistencies" is not an attack Arroyave's principles and methodology, but on his conclusions. The Court, however, must focus on the former rather than the latter. See Nova Consulting Grp., Inc. v. Eng'g Consulting Servs., Ltd., 290 F. App'x 727, 731 (5th Cir. 2008) (noting the court's focus "must be solely on principles and methodology, not on the conclusions they generate"). Defendant is free to attack Arroyave's conclusions and stress any overlooked inconsistencies on crossexamination.
Next, Defendant contends Arroyave's opinion "impermissibly relies on an interpretation of the '394 patent that conflicts with the Court's claims construction ruling." Def.'s Mot. [Dkt. # 119] at 8. Specifically, Defendant criticizes Arroyave's deposition testimony that any liner containing nickel and aluminum would likely produce NiAl. Defendant cites three deposition excerpts in support of its position:
Arroyave Dep. [Dkt. # 119-2] at 133:10-20.
Id. at 135:17-136:3.
Id. at 152:6-24.
To the extent the claim construction order "reject[ed] the argument that any combination of Ni and Al will satisfy" the "respective proportions" limitation, the cited deposition testimony does not conflict with that reasoning. Arroyave did not testify that any combination would satisfy the claim limitation. Instead, he testified that the only way for him to be sure NiAl does not form is to have either zero percent nickel or zero percent aluminum, which is a different proposition. Accordingly, the Court will deny this part of the motion.
Last, Defendant complains about Arroyave's Supplemental Expert Report, which Plaintiff served on July 17, 2018, two days before Arroyave's deposition. Arroyave Dep. [Dkt. # 119-2] at 152:25-153:5. The Supplemental Report is 7 pages long and appears primarily directed to criticizing Dr. Lograsso's opinions and conclusions as exceeding what can be supported by SEM/EDS testing. See Arroyave Supp. Rep. [Dkt. # 119-6]. In that regard, the Supplemental Report is really a rebuttal report in that it responds to affirmative opinions proffered in Dr. Lograsso's June 22, 2018 Rebuttal Report.
Plaintiff did not move for leave to serve the report and provided a copy only shortly before Arroyave's deposition. See generally Arroyave Dep. [Dkt. # 119-2] at 133:10-20. Defendant contends Plaintiff provided no explanation or authority for the Supplement Report. Def.'s Mot. [Dkt. # 119] at 9-10. Defendant was therefore left with little time to prepare for Arroyave's deposition as to the content of the Supplemental Report, and has no ability for an expert to respond.Id. at 12. Plaintiff responds that Arroyave's opinions are strictly limited to the testing performed by Lograsso. Pl.'s Resp. [Dkt. # 143] at 12-14.
The Court's docket control orders do not normally contemplate surrebuttal reports. The Court, however, will deny Defendant's motion on this point because Arroyave's rebuttal is short and focused on affirmative testimony found in Lograsso's report. Given the late disclosure by Plaintiff—less than two days before Arroyave's deposition—Defendant may take a short telephonic deposition of Dr. Arroyave concerning his Supplemental Report prior to his testimony at trial.